Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Revenue (2024 - 2026)

Invivyd's (IVVD) quarterly Revenue came in at $14.3 million in Q2 2026, up 21.2% on a YoY basis from $11.8 million in Q2 2025, and down 16.98% quarter-over-quarter from $17.2 million in Q4 2025.

Analysis

Invivyd (IVVD) Revenue (2024 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Revenue for 3 consecutive years, with $14.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Revenue rose 21.2% year-over-year to $14.3 million; the trailing twelve-month figure through Jun 2026 stood at $56.4 million (up 22.07% YoY), and the FY2025 full-year result was $53.4 million, up 110.47% from the prior year.
  • Revenue declined to $14.3 million in Q2 2026 per IVVD's latest filing, from $17.2 million in the prior quarter.
  • Across five years, Revenue topped out at $17.2 million in Q4 2025 and bottomed at $2.3 million in Q2 2024.
  • Historically, Revenue has averaged $11.6 million across 3 years, with a median of $12.5 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Revenue jumped 420.58% in 2025, then climbed 21.2% in 2026.
  • Over 3 years, Revenue stood at $13.8 million in 2024, then gained by 24.51% to $17.2 million in 2025, then dropped by 16.98% to $14.3 million in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $14.3 million, $17.2 million, and $13.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.52 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 1.29 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 2.74 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 425.49 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 14.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.29 Mn
Dec 31, 2025 17.21 Mn
Sep 30, 2025 13.13 Mn
Jun 30, 2025 11.79 Mn
Mar 31, 2025 11.30 Mn
Dec 31, 2024 13.82 Mn
Sep 30, 2024 9.30 Mn
Jun 30, 2024 2.26 Mn